BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22977142)

  • 1. Taught a lesson by taut skin.
    Geoghegan P; Sexton DJ; Giblin L; O'Regan A
    BMJ; 2012 Sep; 345():e5971. PubMed ID: 22977142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of scleroderma renal crisis in a patient with undiagnosed scleroderma].
    Madsen KL; Hansen A; Halberg P; Ullman S
    Ugeskr Laeger; 2014 Dec; 176(25A):. PubMed ID: 25497666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 4. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)].
    Gotoh S; Ogihara T; Hata T; Maruyama A; Naka T; Nakamaru M; Mikami H; Masuo K; Kumahara Y
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1133-41. PubMed ID: 7033607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Converting enzyme inhibitors in preterminal renal failure].
    Rambausek MH; Ritz E
    Dtsch Med Wochenschr; 1992 Jan; 117(2):77. PubMed ID: 1730207
    [No Abstract]   [Full Text] [Related]  

  • 6. [To what extent can prostaglandin synthesis inhibitors of the non-steroidal antirheumatic (NSAR) type modify the effect of ACE inhibitors?].
    Grote L
    Internist (Berl); 1995 Dec; 36(12):1203-4. PubMed ID: 8567229
    [No Abstract]   [Full Text] [Related]  

  • 7. Diffuse alveolar damage and acute kidney injury induced by abusive use of non-steroidal anti-inflammatory drugs: a new and atypical renopulmonary syndrome?
    Quiroga B; Basterrechea MÁ; Fernández-Francés J; de Arriba G
    Intern Med J; 2016 May; 46(5):632-3. PubMed ID: 27170244
    [No Abstract]   [Full Text] [Related]  

  • 8. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of captopril in the treatment of erythrocytosis after renal transplantation.
    Suh BY; Suh JD; Kwun KB
    Transplant Proc; 1996 Jun; 28(3):1557-8. PubMed ID: 8658784
    [No Abstract]   [Full Text] [Related]  

  • 10. Life-threatening hyperkalemia after 2 days of ibuprofen.
    Platts-Mills TF; Richmond NL; Hunold KM; Bowling CB
    Am J Emerg Med; 2013 Feb; 31(2):465.e1-2. PubMed ID: 23407039
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of non-steroidal anti-inflammatory drugs on hypertension control using angiotensin converting enzyme inhibitors and thiazide diuretics.
    Bhagat K
    East Afr Med J; 2001 Oct; 78(10):507-9. PubMed ID: 11921591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practical questions about therapy of hypertension with ACE inhibitors. J. Scholze, Berlin, on the 24-hour effect, possible combinations and side-effects of ACE inhibitors--ASS/antirheumatic agents].
    Scholze J
    Fortschr Med; 1995 Feb; 113(4):51-4. PubMed ID: 7713469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hypertension using converting enzyme inhibitors].
    Kolber-Postepska B
    Wiad Lek; 1987 Aug; 40(16):1104-10. PubMed ID: 3326286
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficacy of Capoten in treating rheumatoid arthritis with arterial hypertension: an analysis of its hypotensive and anti-inflammatory actions].
    Nasonova VA; Samoriadova OS; Masenko VP; Balabanova RM; Nasonov EL
    Ter Arkh; 1992; 64(8):68-73. PubMed ID: 1440402
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
    Stanek B; Templ H; Pohanka E; Silberbauer K
    Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
    [No Abstract]   [Full Text] [Related]  

  • 16. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
    Hradec J
    Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Consulting the ophthalmologist for assessment].
    Füessl HS
    MMW Fortschr Med; 2004 Jul; 146(27-28):57, 59. PubMed ID: 15526677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotensive mechanisms of captopril--a counter-view.
    Lazar AI
    J Assoc Physicians India; 1996 Oct; 44(10):753. PubMed ID: 9251364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.